SJS Investment Consulting’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2
| Closed | -$1.27K | – | 1634 |
|
|
2025
Q1 | $1.27K | Sell |
2
-1
| -33% | -$635 | ﹤0.01% | 915 |
|
|
2024
Q4 | $2.14K | Sell |
3
-5
| -63% | -$3.56K | ﹤0.01% | 675 |
|
|
2024
Q3 | $8.41K | Hold |
8
| – | – | ﹤0.01% | 397 |
|
|
2024
Q2 | $8.41K | Hold |
8
| – | – | ﹤0.01% | 356 |
|
|
2024
Q1 | $7.7K | Hold |
8
| – | – | ﹤0.01% | 386 |
|
|
2023
Q4 | $7.03K | Sell |
8
-3
| -27% | -$2.64K | ﹤0.01% | 336 |
|
|
2023
Q3 | $9.05K | Hold |
11
| – | – | ﹤0.01% | 296 |
|
|
2023
Q2 | $7.91K | Sell |
11
-2
| -15% | -$1.44K | ﹤0.01% | 294 |
|
|
2023
Q1 | $10.7K | Buy |
13
+1
| +8% | +$822 | ﹤0.01% | 282 |
|
|
2022
Q4 | $8.66K | Buy |
12
+6
| +100% | +$4.33K | ﹤0.01% | 297 |
|
|
2022
Q3 | $4K | Buy |
+6
| New | +$4K | ﹤0.01% | 362 |
|
|
2022
Q1 | $18K | Buy |
+26
| New | +$18K | 0.01% | 312 |
|